Flagship startup emerges with $50M

The latest stories trending on MedCity News.

Editor's Pick

Top Story Flagship Startup Emerges With $50M to Send Drugs to the Right Biologic Address Ampersand Biomedicines emerged from stealth with technology for site-specific drug delivery that avoids toxic effects throughout the body. The Flagship Pioneering-founded startup is backed by $50 million in financing. Sponsored Content Join us today! Learn to Leverage Diagnostic Development to Guard Against RSV, Flu and Covid-19 Presented by BD and MedCity News Today's webinar sponsored by BD will explore how diagnostics companies are working with healthcare organizations to guard against the perfect storm of Covid-19, RSV and influenza. Other highlights included are: An overview of the most recent respiratory seasons and what kind of risks are posed by RSV, flu, and other respiratory diseases Clinical presentation and symptoms  The BD Veritor™ Plus System and its benefits Innovations that companies such as BD have enacted to support public health Sign up today! Have You Always Wanted to Ask the CIO? Capitalize on this one of a kind opportunity to meet, connect and ask CIOs from Marshfield Clinic Health System and Tufts Medicine. Plus, you'll get two evening networking receptions in five-star luxury and convenience at the Ritz Carlton when you join us May 22-24 at INVEST 2023 in Chicago. Save $400* with Early Bird Pricing! Register Now

Featured News

Why ChatGPT In Healthcare Could Be a Huge Liability, Per One AI Expert One healthcare AI expert thinks ChatGPT could have dangerous implications for the field if it's not used with the proper context. People already turn to sources like Reddit and TikTok when they have a question about a medical concern they're experiencing — Americans putting too much trust in ChatGPT to answer these questions could make this phenomenon a much bigger problem. WeightWatchers To Acquire Chronic Weight Management Digital Health Platform WeightWatchers will acquire Sequence, a platform that allows patients to have virtual appointments with a clinician, gives access to a dietitian and fitness coaching and provides prescription medications, including Ozempic and Wegovy. The deal is anticipated to close during the second quarter of 2023, and WeightWatchers will pay the net purchase price of $106 million.  Organ Preservation Company Rakes In $24M to Expand Commercial Footprint Paragonix Technologies recently closed a $24 million Series B funding round. The Cambridge, Massachusetts-based company provides transplant centers and organ procurement organizations with medical devices designed for the preservation and transportation of donor organs. 4 Measures Hospitals Should Take to Improve Peripartum Depression Outcomes Peripartum depression is still widely prevalent and represents one of the most critical maternal health risks. Fortunately, evidence-based interventions have been proven effective in mitigating PPD symptoms and improving health outcomes for both mother and infant. Transcarent To Acquire Part of 98point6 for $100M, Gain AI-powered Virtual Care Platform The $100 million deal between Transcarent and 98point6 is expected to close March 31 and is a combination of equity and cash, said Glen Tullman, CEO of Transcarent. Through the acquisition, Transcarent will gain access to 98point6's AI-powered text-based technology, affiliated provider group and client base. Pharmacies Primed to put Patient Needs Back at the Forefront of Care While they've always served as hubs for medication and other basic necessities, now is the time to innovate and remove the burden from the healthcare system. It's time for pharmacies to become central locations for all things health and wellness– diagnostics included. New Hemophilia Data Lead FDA to Delay Decision for BioMarin Gene Therapy BioMarin Pharmaceutical's submission of additional data for patients treated with its hemophilia A gene therapy, Roctavian, mean that the FDA will push out a regulatory decision to early summer. But it could be worth the wait as analysts anticipate FDA approval and project Roctavian becoming one of BioMarin's biggest products. What to Learn From the Department of Justice Criminal Enforcement Guidance There appears to be no slowdown of federal enforcement activity in the healthcare sector in the foreseeable future. Therefore, the DOJ's guidance to prosecutors is especially relevant to this industry and provides useful insights on ways to mitigate risks in the event of criminal enforcement activity. The Influence Data, Digitalization & Diversity Will Have on Medical Affairs in 2023 With the rapid digitization of the entire industry and a new generation of talent waiting in the wings, Medical affairs teams need access to data and modern technology to engage with a new generation of influencers, improve diversity, and develop stronger go-to-market strategies.

Resources

Medcity Pivot Podcast: Chronic Disease Management with an Interventional Cardiologist During this podcast, Steve Driver from Advocate Aurora Health focuses on chronic disease management, digital therapeutics, and remote monitoring especially as it relates to cardiac care and prediabetes.   Listen Now

MedCity News • 611 Broadway • New York, NY unsubscribe